Albemarle Corporation
ALB
$101.27
-0.81%
Albemarle Corporation is a global specialty chemicals company and one of the world's largest lithium producers, operating a fully integrated model that spans upstream brine and hard-rock resources in Chile, the United States, and Australia through downstream refining plants across four continents; its Energy Storage segment supplies battery-grade lithium for electric-vehicle and grid-storage applications, while its Specialties segment holds a leadership position in bromine-based flame retardants and other performance chemicals. The company is best understood as a leveraged play on the lithium price cycle rather than a diversified industrial, since Energy Storage alone generated roughly $1.28 billion of the $1.74 billion in most recent quarterly revenue, making earnings highly sensitive to battery-metal pricing and EV demand trends. The current investor debate centers on whether the sharp collapse in the share price — down roughly 41% over six months and 27% year-to-date — represents a cyclical trough offering deep value, or a structural de-rating as lithium oversupply persists; bulls point to a dramatic profitability inflection with Q2 2026 net income of $480 million versus a loss a year earlier, while bears highlight the stock's 24% one-month decline and the fact that consensus targets remain far above the market price. Recent coverage frames the setup as a potential "lithium-fueled rebound" with a mixed Q4 masking a stronger long-term trajectory, and the stock's inclusion in value-oriented mining screens underscores the tug-of-war between near-term price momentum and longer-cycle fundamentals.…
ALB
Albemarle Corporation
$101.27
Related headlines
Investment Opinion: Should I buy ALB Today?
The synthesized recommendation is a Hold with a speculative bias. The core thesis is that Albemarle offers deep value on forward earnings (9.3x P/E) and substantial analyst upside (63.6% to average target), but the persistent downtrend and lithium oversupply create high uncertainty. The consensus rating is Buy, but the market price is far below targets, indicating a disconnect that may take time to resolve.
Supporting evidence includes the recent profitability inflection (Q2 2026 EPS of $3.72 vs. a loss a year ago), revenue growth of 31.1% year-over-year, and a solid balance sheet with debt-to-equity of 0.35 and $1.34 billion in trailing free cash flow. The forward P/E of 9.26x is attractive compared to the specialty chemicals sector, and the PEG ratio of 0.51 suggests undervaluation relative to growth. However, the trailing net margin is -9.9%, and the stock has fallen 41% in six months, reflecting deep skepticism.
The biggest risks are a continued lithium price decline, another earnings miss, and a break below the 52-week low of $85.85. The rating would upgrade to Buy if lithium prices stabilize and the company delivers consistent profits, or downgrade to Sell if revenue growth turns negative or free cash flow deteriorates. Relative to its own history, the stock is undervalued on forward earnings but may remain cheap if the cycle doesn't turn. It is fairly valued to slightly undervalued for risk-tolerant investors.
Sign up to view all
ALB 12-Month Price Forecast
The forward-looking view is cautiously neutral. The company has demonstrated a strong earnings rebound, but the market is clearly skeptical of its durability given the lithium price cycle. The valuation is attractive on forward earnings, and analyst sentiment is overwhelmingly positive, but the technical trend and macro headwinds are powerful. I would upgrade to bullish if lithium prices show a sustained uptrend and the company delivers two consecutive quarters of strong profits. I would downgrade to bearish if lithium prices break below $10,000/ton or if the company misses earnings expectations.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Albemarle Corporation's 12-month outlook, with a consensus price target around $168.56 and implied upside of +66.5% versus the current price.
Average Target
$168.56
0 analysts
Implied Upside
+66.5%
vs. current price
Analyst Count
—
covering this stock
Price Range
$83 - $225
Analyst target range
Bulls vs Bears: ALB Investment Factors
The bull case rests on a powerful earnings inflection, deep value multiples, and overwhelming analyst optimism, while the bear case emphasizes the relentless downtrend, lithium oversupply, and earnings volatility. Currently, the bear evidence appears stronger because the stock continues to make new lows despite the recent profit, and the market is clearly skeptical of the sustainability of the recovery. The single most important tension is whether lithium prices will stabilize or continue to fall; if they stabilize, the forward P/E of 9.3x and 63% analyst upside could drive a sharp re-rating, but if oversupply persists, the stock could retest its 52-week low of $85.85.
Bullish
- Dramatic profitability inflection: Q2 2026 net income reached $480 million (EPS $3.72) versus a loss of $161 million in Q3 2025 and a loss of $414 million in Q4 2025, marking a sharp turnaround. Revenue grew 31.1% year-over-year to $1.74 billion, with gross margin expanding to 33.9% from 14.8% a year earlier.
- Deep value on forward earnings: The forward P/E is only 9.26x based on estimated EPS of $13.90, while the PEG ratio is 0.51, suggesting the stock is cheap relative to expected growth. The price-to-book ratio of 1.75 is also modest for a company with a strong asset base.
- Strong analyst consensus and upside: 20 analysts rate the stock a 'Buy' with an average target price of $171.06, implying 63.6% upside from the current price of $104.59. The high target of $225 suggests even greater potential if lithium prices recover.
- Solid balance sheet and cash generation: The debt-to-equity ratio is a manageable 0.35, and the current ratio of 2.23 indicates ample liquidity. Free cash flow over the trailing twelve months was $1.34 billion, providing financial flexibility.
Bearish
- Severe price downtrend and relative weakness: The stock has fallen 41.3% over six months, 22.8% over three months, and 24.1% in the past month, significantly underperforming the S&P 500. Relative strength over six months is -58.6%, indicating persistent selling pressure.
- Earnings volatility and recent losses: Despite the recent profit, the trailing twelve-month EPS is negative (-$0.03), and the company reported large losses in three of the last five quarters. Net margin is -9.9%, and operating margin is only 1.8%, highlighting fragile profitability.
- Lithium oversupply and pricing pressure: The core risk is a sustained lithium surplus that keeps prices depressed. The stock's 52-week low of $85.85 is 17.9% below the current price, and the analyst low target of $83.28 implies further downside if oversupply persists.
- High EV/EBITDA and negative PE: The EV/EBITDA ratio is 32.7x, which is elevated for a cyclical materials company, and the trailing P/E is negative due to losses. This suggests the market is pricing in a strong recovery that may not materialize.
ALB Technical Analysis
Beta
1.36
1.36x market volatility
Max Drawdown
-53.0%
Largest decline past year
52-Week Range
$88-$221
Price range past year
Annual Return
+4.9%
Cumulative gain past year
| Period | ALB Return | S&P 500 |
|---|---|---|
| 1m | -19.6% | +2.1% |
| 3m | -19.7% | +3.1% |
| 6m | -41.7% | +14.6% |
| 1y | +4.9% | +16.0% |
| ytd | -29.6% | +14.2% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
ALB Fundamental Analysis
Quarterly Revenue
$1.7B
2026-06
Revenue YoY Growth
+31.1%
YoY Comparison
Gross Margin
33.9%
Latest Quarter
Free Cash Flow
$1.3B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is ALB Overvalued?
PE
-24.6x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 5x~26x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
32.8x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks are significant. Although debt-to-equity is a reasonable 0.35 and the current ratio is 2.23, the company's profitability is highly volatile, with a trailing net margin of -9.9% and operating margin of just 1.8%. The Q2 2026 profit of $480 million was a sharp reversal from losses in prior quarters, but it relied on a 31% revenue jump that may not be repeatable if lithium prices fall. Additionally, the payout ratio is negative, and the dividend yield of 2.15% may be at risk if earnings decline again. The company's heavy concentration in lithium (Energy Storage was ~73% of Q2 revenue) makes it vulnerable to a single commodity cycle.
Market and competitive risks are elevated. The stock trades at a high EV/EBITDA of 32.7x and a price-to-sales of 3.24x, which may not be sustainable if growth slows. With a beta of 1.33, it is more volatile than the market, and the 24% one-month decline shows how quickly sentiment can shift. The lithium market remains oversupplied, and competitors in Australia and China could pressure prices further. Recent news about SpaceX's IPO and capital rotation out of space stocks is unrelated, but it highlights how quickly capital can move away from speculative sectors. Regulatory risks in Chile, where Albemarle operates brine assets, could also impact production.
The worst-case scenario involves a continued lithium price slump leading to another quarter of losses, which would likely push the stock below its 52-week low of $85.85. From the current price of $104.59, that represents a 17.9% decline, and the analyst low target of $83.28 implies a 20.4% drop. If lithium prices fall to marginal cost levels, the stock could revisit its all-time lows, and the max drawdown of 51.5% over the past year shows the potential severity. Investors could lose a significant portion of their capital if the cyclical downturn extends.
FAQ
The most severe risk is a continued lithium price decline, which could push the company back into losses and drive the stock below its 52-week low of $85.85. Financial risks include high earnings volatility (trailing net margin -9.9%) and a negative payout ratio, which may threaten the dividend. Competitive risks stem from global lithium oversupply, particularly from Australian and Chinese producers. Macro risks include a beta of 1.33, making the stock more sensitive to market downturns, and potential regulatory changes in Chile that could disrupt operations.
Our 12-month forecast has a base case (50% probability) of $120-$150, assuming lithium prices stabilize and the company maintains profitability. The bull case (25% probability) targets $171-$225 if lithium prices recover sharply and earnings beat expectations. The bear case (25% probability) targets $83-$100 if oversupply persists and the company returns to losses. The most likely scenario is the base case, hinging on lithium prices remaining range-bound and the company executing on cost controls.
On forward earnings, ALB appears undervalued with a P/E of 9.26x and a PEG ratio of 0.51, well below typical specialty chemical peers. However, the trailing P/E is negative due to recent losses, and the EV/EBITDA of 32.7x is elevated, indicating that the market is pricing in a strong recovery. Relative to its own history, the price-to-book of 1.75 is near multi-year lows, suggesting the stock is cheap if the cycle turns. The market is currently paying a discount due to uncertainty, but the valuation implies expectations of a return to profitability.
Albemarle presents a high-risk, high-reward opportunity. The stock trades at a forward P/E of 9.26x and has 63.6% upside to the analyst average target of $171.06, which suggests it is undervalued if earnings estimates are met. However, the company reported a trailing net loss and the stock is down 41% over six months, reflecting deep concerns about lithium oversupply. For risk-tolerant investors with a long horizon, it could be a good buy on further weakness, but for most investors, waiting for a confirmed turnaround in lithium prices is prudent.
ALB is better suited for long-term investors who can withstand cyclical downturns, given its high beta of 1.33 and 51.5% max drawdown over the past year. The dividend yield of 2.15% is modest and not covered by trailing earnings, so it is not an income play. Short-term trading is risky due to the stock's sharp momentum swings, as seen in the 24% one-month decline. A minimum holding period of 2-3 years is recommended to allow the lithium cycle to play out and for the company's investments to bear fruit.